Immune checkpoint inhibitors in liver transplantation: Current practice, challenges, and opportunities
Sean P. Martin,
Neil Mehta,
Juliet Emamaullee
Abstract:Immune checkpoint inhibitors are becoming a mainstay of cancer treatment. While first studied and approved for patients with unresectable disease, due to their efficacy they are becoming increasingly used in the perioperative period across many cancer types. In patients with hepatocellular carcinoma (HCC), immune checkpoint inhibitors have now become standard of care in the advanced setting and have shown promising results in the adjuvant setting after liver resection. While these drugs continue to show promis… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.